Nano-X Imaging Ltd. (NNOX)
NASDAQ: NNOX · Real-Time Price · USD
3.030
+0.010 (0.33%)
At close: Jan 6, 2026, 4:00 PM EST
3.064
+0.034 (1.12%)
After-hours: Jan 6, 2026, 7:56 PM EST
Nano-X Imaging Market Cap
Nano-X Imaging has a market cap or net worth of $209.7 million as of January 6, 2026. Its market cap has decreased by -50.98% in one year.
Market Cap
209.70M
Enterprise Value
172.40M
1-Year Change
-50.98%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since the IPO on August 21, 2020, Nano-X Imaging's market cap has decreased from $746.15M to $209.70M, a decrease of -71.90%. That is a compound annual growth rate of -21.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 209.01M | 7.86% |
| Dec 31, 2025 | 193.79M | -54.01% |
| Dec 31, 2024 | 421.36M | 14.58% |
| Dec 29, 2023 | 367.76M | -4.66% |
| Dec 30, 2022 | 385.74M | -48.67% |
| Dec 31, 2021 | 751.50M | -64.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.51B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |